BP000508-PKA-348: Recombinant Human Tyr-3/Trp-5 Monooxygenase Activation Beta Protein
Source: E. coli-derived.
Purity > 90%, by RP-HPLC and SDS-PAGE.BP000511-PKA-347: Recombinant Human Tyr-3/Trp-5 Monooxygenase Activation ETA Protein
Source: E. coli-derived.
Purity > 95%, by SDS-PAGE.BP000510-PKA-238: Recombinant Human Tyr-3/Trp-5 Monooxygenase Activation Gamma Protein
Source: E. coli-derived.
Purity > 95%, by RP-HPLC and SDS-PAGE.BP000510-PKA-262: Recombinant Human Tyr-3/Trp-5 Monooxygenase Activation Gamma Protein, His Tag
Source: E. coli-derived.
Purity > 95%, by SDS-PAGE.BP000512-PKA-254: Recombinant Human Tyr-3/Trp-5 Monooxygenase Activation Theta Protein
Source: E. coli-derived.
Purity > 95%, by RP-HPLC and SDS-PAGE.BP000094-CYT-137: Recombinant Human 4-1BB Receptor, His Tag
Source: E. coli-derived.
Purity: > 90% as determined by SDS-PAGE.BP000094-CYT-463: Recombinant Human 4-1BB Receptor
Source: E. coli-derived.
The activity was determined by the inhibition of 4-1BB ligand mediated stimulation of IL-8 production by human PBMC. Results: 90% inhibition using 1 for both 4-1BB ligand and 4-1BB receptor.
Purity > 98%, by SDS-PAGE and RP-HPLC.- IA000083-S-3003
Used to incorporate Boc-protected HyNic (6-hydrazinonicotinamide) moieties during solid or solution phase peptide synthesis - IA000051-S-3034
6-Fmoc-Lysine-(6-Boc-HyNic) is used to incorporate HyNic (6-hydrazinonicotinamide) moieties on the C-terminus and internal positions during solid or solution phase peptide synthesis APIM050070: A-769662
CAS No.: 844499-71-4.
Purity: >99% (HPLC at 254 nm), >98.5% (HPLC at 214nm).
QC: 1HNMR, HPLC.
Solubility: Soluble in DMSO (200 mM) and Ethanol (to 25 mM).